PEMGX | WSMRX | PEMGX / WSMRX | |
Total Expense Ratio | 0.91 | 0.94 | 97% |
Annual Report Gross Expense Ratio | 0.91 | 0.98 | 93% |
Fund Existence | 20 years | 6 years | - |
Gain YTD | 7.790 | -3.197 | -244% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 33.2B | 1.41B | 2,353% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 9.88 | -9.71 | -102% |
Returns for 3 years | 39.59 | -0.95 | -4,189% |
Returns for 5 years | 47.06 | -8.50 | -554% |
Returns for 10 years | 119.88 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 9.35 | 0.21 | +2.25% |
Global X Genomics & Biotechnology ETF | |||
IWR | 96.12 | 2.11 | +2.24% |
iShares Russell Mid-Cap ETF | |||
DMXF | 75.78 | 1.14 | +1.53% |
iShares ESG Advanced MSCI EAFE ETF | |||
MYCK | 25.06 | 0.16 | +0.63% |
SPDR SSGA My2031 Corporate Bond ETF | |||
OPP | 8.59 | 0.03 | +0.35% |
RiverNorth/DoubleLine Strategic Opportunity Fund |